Remedent (Remedent) Stock Based Compensation : $0.00 Mil (TTM As of Dec. 2020)

View and export this data going back to 2000. Start your Free Trial

What is Remedent Stock Based Compensation?

Remedent's Stock Based Compensation for the three months ended in Dec. 2020 was $0.00 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Dec. 2020 was $0.00 Mil.

Remedent Stock Based Compensation Historical Data

The historical data trend for Remedent's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Remedent Stock Based Compensation Chart

Remedent Annual Data

Trend

Mar11

Mar12

Mar13

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Stock Based Compensation

Get a 7-Day Free Trial

Remedent Quarterly Data
	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20
Stock Based Compensation	Get a 7-Day Free Trial															-	-	-	-	-

Remedent Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Dec. 2020 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

Remedent Stock Based Compensation Related Terms

Thank you for viewing the detailed overview of Remedent's Stock Based Compensation provided by GuruFocus.com. Please click on the following links to see related term pages.

Remedent (Remedent) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Remedent Inc (OTCPK:REMI) » Definitions » Stock Based Compensation

Comparable Companies

Traded in Other Exchanges

N/A

Address

Zuiderlaan 1-3, Box 8, Ghent, BEL, 9000

Website

https://www.remedent.com

Remedent Inc is a manufacturer of cosmetic dentistry products in Europe. The company is engaged in the research, development, and manufacturing of oral care and cosmetic dentistry products. It designs, develops, manufactures, and distributes cosmetic dentistry products, including a full line of professional dental products that are distributed in Europe, Asia, the Middle East, and the United States. The product line of the company includes SmileWise, the SmileMe mirror, and the Condor intra-oral 3D scanner.

Executives

Stuart Steinberg	10 percent owner	85 BELLEVUE AVENUE, RYE NY 10580
Marxe Austin W & Greenhouse David M	10 percent owner	C/O SPECIAL SITUATIONS FUNDS, 527 MADISON AVENUE, SUITE 2600, NEW YORK NY 10022
Gruber & Mcbaine Capital Management Llc	10 percent owner	234 VAN NESS, STE 5, SAN FRANCISCO CA 94133
Stephen Farley Ross	director, officer: CFO; Secretary	XAVIER DE COCKLAAN 42 DEURLE C9 9831
Fred Kolsteeg	director	XAVIER DE COCKLAAN 42 DEURLE C9 9831
Acker Philippe Van	director	C/O REMEDENT, INC. XAVIER DE COCKLAAN 42 9831 DEURLE C9 9831
Robin List	other: Former Officer and Director	XAVIER DE COCKLAAN 42 DEURLE C9 9831
Roger Leddington	officer: Sr VP & Head of US Marketing	C/O REMEDENT, INC. XAVIER DE COCKLAAN 42 DEURLE C9 9831
Guy Devreese	director, officer: Chairman of the Board	XAVIER DE COCKLAAN 42 DEURLE C9 9831
Judd Darrin Hoffman	officer: VP Worldwide Sales/Operations	702A JUANITA AVENUE REDONDO BEACH CA 90277
Nv Lausha	10 percent owner	C/O REMEDENT, INC. XAVIER DE COCKLAAN 42 9831 DEURLE C9 9831

Remedent (Remedent) Headlines

From GuruFocus

Making Money from Smiles

By Frank Lind Frank Lind • 05-26-2011